Exam (elaborations)
Exam 3: NURS617/ NURS 617 (Latest 2024/ 2025 Update) Pharmacotherapeutics Review| Qs & As| Grade A| 100% Correct (Verified Answers)- Southeastern Louisiana
Exam 3: NURS617/ NURS 617 (Latest 2024/ 2025 Update) Pharmacotherapeutics Review| Qs & As| Grade A| 100% Correct (Verified Answers)- Southeastern Louisiana
Q: Which thyroid medication is most cardiotoxic
Answer:
Liothyronine
Q: Which thyroid medication has the disadvantage of not ha...
[Show more]
Preview 3 out of 21 pages
Uploaded on
December 5, 2024
Number of pages
21
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
southeastern louisiana pharmacotherapeutics exam
1
southeastern louisiana pharmacotherapeutics exam 2
southeastern louisiana pharmacotherapeutics exam 3
southeastern louisiana pharmacotherapeutics exa
$10.99
Also available in package deal from $13.99
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (3)
1. Exam (elaborations) - exam 3: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide| qs ...
2. Exam (elaborations) - Exam 3: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
Show more
1. Exam (elaborations) - exam 3: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide| qs ...
2. Exam (elaborations) - Exam 3: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
3. Exam (elaborations) - Final exam: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review|...
4. Exam (elaborations) - Final exam: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide| ...
Show more
1. Exam (elaborations) - Exam 1: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics | qs & as| ...
2. Exam (elaborations) - exam 3: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide| qs ...
3. Exam (elaborations) - Exam 1: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
4. Exam (elaborations) - Exam 2: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide | qs ...
5. Exam (elaborations) - Exam 2: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
6. Exam (elaborations) - Exam 3: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
7. Exam (elaborations) - Final exam: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review|...
8. Exam (elaborations) - Final exam: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide| ...
Show more
Examl3:lNURS617/lNURSl617l(Latestl
Update)lPharmacotherapeuticslReview|lQsl
&lAs|lGradelA|l100%lCorrectl(Verifiedl
Answers)-lSoutheasternlLouisiana
Q:lWhichlthyroidlmedicationlislmostlcardiotoxic
Answer:
Liothyronine
Q:lWhichlthyroidlmedicationlhasltheldisadvantageloflnotlhavinglcontentlstability
Answer:
Liotrix
Q:lWhatlarelsomeladvantagesloflLiothyronineloverlLevothyroxine
Answer:
Liothyroninelhaslalfasterlonsetloflactionlandlislmorelpotent.
Q:lAdvantageloflusinglLevothyroxineloverlLiothyronine
Answer:
Lesslcardiotoxiclandlhaslallongerldurationloflactionlmeaninglthatlevenliflsomeldoseslarelmissed
lthyroidllevelslcanlremainltherapeutic.
,Q:lWhatlarelsomelsignsloflThyroidlmedicationltoxicity?
Answer:
irritability,linsomnia,ltachycardia,larrhythmias,lelevatedlbloodlpressure,lanxiety,lweightlloss,lalll
similarlsignsloflhyperthyroidism.
Q:lWhichlantithyroidldruglislusedlinlpregnancy
Answer:
Propylthiouracil
Q:lWhichlantithyroidldruglhaslalblacklboxlwarninglforlliverlinjury
Answer:
Propylthiouracil
Q:lAdvantagesloflMethimazoleloverlPropylthiouracil
Answer:
Methimazolelislmorelpotent,llessltoxic,lnotlproteinlbound,landldoeslnotlcarrylblacklboxlwarnin
glaboutlliverldamage
Q:lWhatladverselreactionslcanlantithyroidlmedicationslcause
Answer:
, Allergiclreactionslsuchlaslrash,landlurticaria;lNausealandlvomitinglduringlinitiationlofltherapy;l
agranulocytosislandlthrombocytopenia;lHypothyroidisml(withllongltermltherapy);lreoccurrencel
oflhyperthyroidismlafterlstoppingltreatment.
Q:lWhichlantidiabeticslcauselhypoglycemia
Answer:
Sulfonylureas,lmeglitinides,lamylinlagonistslcanlalllcauselhypoglycemia.l
Thiazolidinediones,lAlphalGlucoselinhibitors,landlGLP-
1lanalogslcanlpotentiatelhypoglycemialwhenlgivenlwithlotherlantidiabetics.
Q:lWhichlanti-diabeticslarelnephroprotective
Answer:
DPP-4l(-
gliptins)lbecauselinlpatientslwithoutlseverelrenallimpairment,ltheltypicallprogressionloflmicroal
buminurialtolproteinurialinlDMlappearsltolbelreversedlafterl2lyearslonlsaxagliptinluse
Q:lWhichlanti-diabeticslrequireldosageladjustmentslforlrenallimpairment.
Answer:
DPP-4l(gliptins)landlSGLT-2linhibitorslrequireldosageladjustmentslwhilel
MetforminlandlSulfonylureaslarelcontraindicatedlinlpatientslwithlrenallfailure.
Q:lWhichlanti-diabeticlmedicationslarelcontraindicatedlinlLiverldisease
Answer:
Metformin,lSulfonylureas,landlThiazolidinediones